NEOG: Neogen Corporation Stock

by  •  • Comments Off on NEOG: Neogen Corporation Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 1,863.55
Enterprise Value ($M) 2,613.19
Book Value ($M) 2,669.07
Book Value / Share 12.30
Price / Book 0.70
NCAV ($M) -814.58
NCAV / Share -3.75
Price / NCAV -2.29

Profitability (mra)
Return on Invested Capital (ROIC) -0.13
Return on Assets (ROA) -0.10
Return on Equity (ROE) -0.15

Liquidity (mrq)
Quick Ratio 2.46
Current Ratio 3.77

Balance Sheet (mrq) ($M)
Current Assets 570.45
Assets 4,054.09
Liabilities 1,385.02
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Select Equity Group, L.P. 4.30 -29.04
02-12 13G/A Baillie Gifford & Co 4.50
11-14 13G William Blair Investment Management, Llc 6.10

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-01-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-10-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-07-30 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-04-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-03 800,512 3,151,471 25.40
2025-04-02 724,811 3,093,632 23.43
2025-04-01 1,349,842 4,005,682 33.70
2025-03-31 705,199 2,436,727 28.94

(click for more detail)

Similar Companies
MRVI – Maravai LifeSciences Holdings, Inc. MYGN – Myriad Genetics, Inc.
NBIX – Neurocrine Biosciences, Inc. NKTX – Nkarta, Inc.
NMRA – Neumora Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io